{"id":3440,"date":"2022-02-10T15:52:00","date_gmt":"2022-02-10T13:52:00","guid":{"rendered":"https:\/\/teknologiateollisuus.fi\/healthtech\/?p=3440"},"modified":"2024-10-01T13:55:21","modified_gmt":"2024-10-01T10:55:21","slug":"timo-hanninen-appointed-ceo-of-injeq-oy","status":"publish","type":"post","link":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/","title":{"rendered":"Timo H\u00e4nninen appointed CEO of Injeq Oy"},"content":{"rendered":"\n<p><strong>Timo H\u00e4nninen, Ph.D., MBA, has been appointed CEO of Injeq Oy.&nbsp;H\u00e4nninen will take up his position at 14.2.2022. H\u00e4nninen has previously served as the CEO of RUAG Space Finland Oy AB.<\/strong><\/p>\n\n\n\n<p><strong>Timo H\u00e4nninen<\/strong>&nbsp;is a professional with a long experience in managing technology organizations. He has extensive experience in international business development and strategy. During his career, H\u00e4nninen has worked in the fields of medical technology, cyber security and space technology, as well as in management positions at Nokia Corporation for almost 20 years.<\/p>\n\n\n\n<p>H\u00e4nninen&#8217;s educational background is also diverse. He did his Master\u2019s thesis on medical technology, his MBA work dealt with Nokia\u2019s ethical management, and his dissertation focused on the Investor Reactions to Corporate Merger and Acquisition Announcements.<\/p>\n\n\n\n<p>H\u00e4nninen is interested in Injeq\u2019s high technology and the global market. It is also important to him that Injeq is a Finnish company whose product can improve people&#8217;s lives. \u201cInjeq is a truly international company that creates something new. I see the purpose of the work as an important motivating factor\u201d, says H\u00e4nninen.<\/p>\n\n\n\n<p>H\u00e4nninen describes himself as a pragmatic value leader who leads based on facts. \u201cI am an open, listener and respect everyone in the organization. I want to challenge the organization, and as a team player, I believe in innovation through individuals and working together\u201d, H\u00e4nninen estimates.<\/p>\n\n\n\n<p>\u201cI am very pleased that a management professional CEO with extensive experience and a solid business vision has been appointed to Injeq. We are an international growth company in medical high-technology that needs expertise like H\u00e4nninen\u201d, says Injeq&#8217;s Chairman of the Board and Acting CEO&nbsp;<strong>Tommi Rasila<\/strong>.<\/p>\n\n\n\n<p>H\u00e4nninen has solid experience in bringing new technology into markets. While at Nokia, he was selling cellular networks to areas where even the wired telephone networks were not working perfectly.<\/p>\n\n\n\n<p><strong>Further information<\/strong><\/p>\n\n\n\n<p>Injeq Oy<\/p>\n\n\n\n<p>Tommi Rasila, Chairman of the Board, Acting CEO<br>tel. +358&nbsp;40 750 8158<br>tommi.rasila(at)injeq.com<\/p>\n\n\n\n<p>Timo H\u00e4nninen, CEO since 14.2.2022<br>tel. +358&nbsp;50 518 1830<br>timo.hanninen(at)injeq.com<\/p>\n\n\n\n<p><strong><em>Injeq in brief<\/em><\/strong><\/p>\n\n\n\n<p><em>Injeq Oy is a Finnish growth company in innovative medical technology, whose mission is to produce technically intelligent solutions for medically demanding patient injections. Developed at the request of physicians, the IQ-Tip\u00ae smart needle facilitates physicians&#8217; work to improve patient safety and treatment effectiveness.<\/em><\/p>\n\n\n\n<p><em>The IQ-Tip\u00ae smart needle is a modern way to perform demanding patient injections safely. The first stage is lumbar puncture, a clinical procedure in which the spinal fluid is sampled or a drug is administered into the spinal cavity. The clinical performance and safety of the product at lumbar punctures have been evaluated in three clinical trials in Finnish university hospitals. The smart needle is suitable for lumbar puncture from newborns to the elderly, one of the main uses being for the treatment of leukemia children.<\/em><\/p>\n\n\n\n<p><em>Founded in 2010, Injeq operates in Tampere and currently employs 16 people. Injeq is supported by an experienced team of medical experts and extensive scientific research. IQ-Tip\u00ae is a registered trademark of Injeq.<\/em><\/p>\n\n\n\n<p><a href=\"https:\/\/eur01.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fpublish.ne.cision.com%2Fl%2Fbuwzbwhlc%2Finjeq.com&amp;data=04%7C01%7Ckirsi.sorri%40teknologiateollisuus.fi%7C28be062cc52541b3ccef08d9ec9aec0e%7Cf76946dcd9fc4b0882aadb1d2a9b8ed0%7C0%7C0%7C637800972385118968%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&amp;sdata=LETL77D6%2Fzx6vHIP3eouIM3EjMqRCSxq3eCRtRdSk7g%3D&amp;reserved=0\">www.injeq.com<\/a><\/p>\n\n\n\n<div class=\"wp-block-scb-columns scb-columns  has-mobile-behavior--stacked em-pattern-event-contacts\">\n<div class=\"wp-block-scb-column scb-column\">\n<h2 class=\"wp-block-heading\" id=\"lisatietoja\">Lis\u00e4tietoja<\/h2>\n\n\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Timo H\u00e4nninen, Ph.D., MBA, has been appointed CEO of Injeq Oy.&nbsp;H\u00e4nninen will take up his position at 14.2.2022. H\u00e4nninen has previously served as the CEO of RUAG Space Finland Oy AB. Timo H\u00e4nninen&nbsp;is a professional with a long experience in managing technology organizations. He has extensive experience in international business development and strategy. During his [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":1064,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"3434,1459,734,706,1365,2132","_relevanssi_noindex_reason":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"em_industry":[],"em_theme":[],"class_list":["post-3440","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uutinen"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Timo H\u00e4nninen appointed CEO of Injeq Oy - Terveysteknologia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/\" \/>\n<meta property=\"og:locale\" content=\"fi_FI\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Timo H\u00e4nninen appointed CEO of Injeq Oy\" \/>\n<meta property=\"og:description\" content=\"Timo H\u00e4nninen, Ph.D., MBA, has been appointed CEO of Injeq Oy.&nbsp;H\u00e4nninen will take up his position at 14.2.2022. H\u00e4nninen has previously served as the CEO of RUAG Space Finland Oy AB. Timo H\u00e4nninen&nbsp;is a professional with a long experience in managing technology organizations. He has extensive experience in international business development and strategy. During his [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/\" \/>\n<meta property=\"og:site_name\" content=\"Terveysteknologia\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-10T13:52:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-01T10:55:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/07\/Timo-Hanninen-Injeq.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"321\" \/>\n\t<meta property=\"og:image:height\" content=\"298\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"P\u00e4ivi Ahlgren\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Kirjoittanut\" \/>\n\t<meta name=\"twitter:data1\" content=\"P\u00e4ivi Ahlgren\" \/>\n\t<meta name=\"twitter:label2\" content=\"Arvioitu lukuaika\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuuttia\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/\"},\"author\":{\"name\":\"P\u00e4ivi Ahlgren\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/#\\\/schema\\\/person\\\/964d40eb9a84d0edfc1989b7784ea950\"},\"headline\":\"Timo H\u00e4nninen appointed CEO of Injeq Oy\",\"datePublished\":\"2022-02-10T13:52:00+00:00\",\"dateModified\":\"2024-10-01T10:55:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/\"},\"wordCount\":524,\"image\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/wp-content\\\/uploads\\\/sites\\\/8\\\/2024\\\/07\\\/Timo-Hanninen-Injeq.jpg\",\"articleSection\":[\"Uutinen\"],\"inLanguage\":\"fi\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/\",\"url\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/\",\"name\":\"Timo H\u00e4nninen appointed CEO of Injeq Oy - Terveysteknologia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/wp-content\\\/uploads\\\/sites\\\/8\\\/2024\\\/07\\\/Timo-Hanninen-Injeq.jpg\",\"datePublished\":\"2022-02-10T13:52:00+00:00\",\"dateModified\":\"2024-10-01T10:55:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/#\\\/schema\\\/person\\\/964d40eb9a84d0edfc1989b7784ea950\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/#breadcrumb\"},\"inLanguage\":\"fi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fi\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/wp-content\\\/uploads\\\/sites\\\/8\\\/2024\\\/07\\\/Timo-Hanninen-Injeq.jpg\",\"contentUrl\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/wp-content\\\/uploads\\\/sites\\\/8\\\/2024\\\/07\\\/Timo-Hanninen-Injeq.jpg\",\"width\":321,\"height\":298,\"caption\":\"Timo H\u00e4nninen\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/timo-hanninen-appointed-ceo-of-injeq-oy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Etusivu\",\"item\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ajankohtaista\",\"item\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/ajankohtaista\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Uutinen\",\"item\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/ajankohtaista\\\/?categories=14\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Timo H\u00e4nninen appointed CEO of Injeq Oy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/#website\",\"url\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/\",\"name\":\"Terveysteknologia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fi\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/teknologiateollisuus.fi\\\/healthtech\\\/#\\\/schema\\\/person\\\/964d40eb9a84d0edfc1989b7784ea950\",\"name\":\"P\u00e4ivi Ahlgren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fi\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g\",\"caption\":\"P\u00e4ivi Ahlgren\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Timo H\u00e4nninen appointed CEO of Injeq Oy - Terveysteknologia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/","og_locale":"fi_FI","og_type":"article","og_title":"Timo H\u00e4nninen appointed CEO of Injeq Oy","og_description":"Timo H\u00e4nninen, Ph.D., MBA, has been appointed CEO of Injeq Oy.&nbsp;H\u00e4nninen will take up his position at 14.2.2022. H\u00e4nninen has previously served as the CEO of RUAG Space Finland Oy AB. Timo H\u00e4nninen&nbsp;is a professional with a long experience in managing technology organizations. He has extensive experience in international business development and strategy. During his [&hellip;]","og_url":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/","og_site_name":"Terveysteknologia","article_published_time":"2022-02-10T13:52:00+00:00","article_modified_time":"2024-10-01T10:55:21+00:00","og_image":[{"width":321,"height":298,"url":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/07\/Timo-Hanninen-Injeq.jpg","type":"image\/jpeg"}],"author":"P\u00e4ivi Ahlgren","twitter_card":"summary_large_image","twitter_misc":{"Kirjoittanut":"P\u00e4ivi Ahlgren","Arvioitu lukuaika":"4 minuuttia"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/#article","isPartOf":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/"},"author":{"name":"P\u00e4ivi Ahlgren","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/#\/schema\/person\/964d40eb9a84d0edfc1989b7784ea950"},"headline":"Timo H\u00e4nninen appointed CEO of Injeq Oy","datePublished":"2022-02-10T13:52:00+00:00","dateModified":"2024-10-01T10:55:21+00:00","mainEntityOfPage":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/"},"wordCount":524,"image":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/#primaryimage"},"thumbnailUrl":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/07\/Timo-Hanninen-Injeq.jpg","articleSection":["Uutinen"],"inLanguage":"fi"},{"@type":"WebPage","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/","url":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/","name":"Timo H\u00e4nninen appointed CEO of Injeq Oy - Terveysteknologia","isPartOf":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/#website"},"primaryImageOfPage":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/#primaryimage"},"image":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/#primaryimage"},"thumbnailUrl":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/07\/Timo-Hanninen-Injeq.jpg","datePublished":"2022-02-10T13:52:00+00:00","dateModified":"2024-10-01T10:55:21+00:00","author":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/#\/schema\/person\/964d40eb9a84d0edfc1989b7784ea950"},"breadcrumb":{"@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/#breadcrumb"},"inLanguage":"fi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/"]}]},{"@type":"ImageObject","inLanguage":"fi","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/#primaryimage","url":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/07\/Timo-Hanninen-Injeq.jpg","contentUrl":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-content\/uploads\/sites\/8\/2024\/07\/Timo-Hanninen-Injeq.jpg","width":321,"height":298,"caption":"Timo H\u00e4nninen"},{"@type":"BreadcrumbList","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/timo-hanninen-appointed-ceo-of-injeq-oy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Etusivu","item":"https:\/\/teknologiateollisuus.fi\/healthtech\/"},{"@type":"ListItem","position":2,"name":"Ajankohtaista","item":"https:\/\/teknologiateollisuus.fi\/healthtech\/ajankohtaista\/"},{"@type":"ListItem","position":3,"name":"Uutinen","item":"https:\/\/teknologiateollisuus.fi\/healthtech\/ajankohtaista\/?categories=14"},{"@type":"ListItem","position":4,"name":"Timo H\u00e4nninen appointed CEO of Injeq Oy"}]},{"@type":"WebSite","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/#website","url":"https:\/\/teknologiateollisuus.fi\/healthtech\/","name":"Terveysteknologia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/teknologiateollisuus.fi\/healthtech\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fi"},{"@type":"Person","@id":"https:\/\/teknologiateollisuus.fi\/healthtech\/#\/schema\/person\/964d40eb9a84d0edfc1989b7784ea950","name":"P\u00e4ivi Ahlgren","image":{"@type":"ImageObject","inLanguage":"fi","@id":"https:\/\/secure.gravatar.com\/avatar\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d49c8c4a3ac6bce6f1ed1a4445d5b60a53463c32cb6ebcf6e0375dcece39eaca?s=96&d=mm&r=g","caption":"P\u00e4ivi Ahlgren"}}]}},"lang":"fi","translations":{"fi":3440},"pll_sync_post":{},"_links":{"self":[{"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/posts\/3440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/comments?post=3440"}],"version-history":[{"count":1,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/posts\/3440\/revisions"}],"predecessor-version":[{"id":3441,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/posts\/3440\/revisions\/3441"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/media\/1064"}],"wp:attachment":[{"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/media?parent=3440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/categories?post=3440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/tags?post=3440"},{"taxonomy":"em_industry","embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/em_industry?post=3440"},{"taxonomy":"em_theme","embeddable":true,"href":"https:\/\/teknologiateollisuus.fi\/healthtech\/wp-json\/wp\/v2\/em_theme?post=3440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}